EmpiRx Health Launches Infusion Therapy Management Solution to Cut Costs
EmpiRx Health has launched a new Infusion Therapy Management solution to help employers reduce costs and improve oversight of high-cost infusion treatments, announced in a press release.
The program shifts infusion therapies from being covered under medical benefits to pharmacy benefits, a move that increases pricing transparency and rebate opportunities. EmpiRx Health stated that this change can deliver more than 10% in savings for benefit plan sponsors while improving access to copay assistance.
The solution incorporates 24/7 care management and direct engagement with prescribing physicians to ensure appropriate drug selection, dosing, and cost. It also integrates the company’s Medication Optimization (MO) model, which uses AI-powered tools and pharmacist oversight to align treatment plans with clinical and financial goals.
According to the company, clients using the MO model have seen an average 15% reduction in drug spending within the first year, with continued optimization producing further savings over time.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly, Sales & Marketing AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential
This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.
Read more